Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

Allogeneic UCB-derived CAR-T for B-ALL

NCT07256353

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The General Hospital of Western Theater Command Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

NCT07234045

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: China Institute of Hematology and Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)

NCT07213882

Conditions: Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma

NCT07209163

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

NCT07207785

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia Meldola, Forlì-Cesena, Italy

Istituto Clinico Humanitas - U.O. Ematologia Rozzano, Milano, Italy

AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy

Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy

View all 20 locations

View Trial Details

Not Yet Recruiting

Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma

NCT07198373

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)

NCT07197021

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).

NCT07191249

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

NCT07187960

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

Gansu Provincial Hospital Lanzhou, Gansu, China

Sun Yet-Sen University Cancer Certer Guangzhou, Guangdong, China

View all 28 locations

View Trial Details

Not Yet Recruiting

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

NCT07178457

Conditions: Brentuximab Vedotin, Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions